U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation’s GeoMx Products

PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the [...]

Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility

State-of-the-art instrument enhances research in structural biology and protein analysis ZÜRICH--Bruker announces the acceptance of a 1.2 GHz Ascend™ Nuclear Magnetic Resonance (NMR) spectrometer at the Swiss High-field NMR Facility, operated jointly by the University of Basel, ETH Zürich, and the University of Zürich. This state-of-the-art instrument will significantly enhance the research capabilities of several [...]

DKSH Partners with Countstar to Bring Advanced Cell Analysis Solutions to Malaysia

DKSH will utilize its market expansion expertise to introduce Countstar’s innovative cell analysis systems into Malaysia, driving growth in the life sciences and biopharma sectors with cutting-edge technology and comprehensive distribution services. Petaling Jaya, Malaysia – DKSH Business Unit Technology has formed a partnership with Countstar, a leading cell analysis solutions provider, in Malaysia. The [...]

GenBio AI Releases Phase 1 of World’s First Digital Organism to Transform Medical Research

Palo Alto, California – Just as the transistor and microscope unlocked new waves of discovery, today, GenBio AI opens the doors to a new era of scientific exploration with Phase 1 of the world’s first AI-Driven Digital Organism (AIDO). In this first phase, scientists will have access to not one, but six groundbreaking models that [...]

MGI Tech Closes Agreement with Sabin Group to Boost Personalized Medicine in Brazil through Oncological and Germiline Genomics

Partnership helps expand population access to cutting-edge genomic tests SAO PAULO -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, has recently partnered with Sabin Group, one of the largest diagnostic laboratories in Brazil, to improve health detection through genetic sequencing technology. The [...]

CellFE® Announces Strategic Placements with Leading Pharma and Biotech Companies

Proprietary Next-Generation Non-Viral, Non-Electroporative Transfection Platform Gaining Traction in Cell Therapy Market ALAMEDA, Calif.--CellFE®, a disruptive life sciences company marketing non-viral, non-electroporative cell therapy manufacturing tools, today announced several strategic system placements with major pharmaceutical and biotech companies, as well as leading translational medicine centers in the cell therapy market. These placements follow the successful [...]

Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA Ventures

Rapid platform adoption with over 50 biopharma and academic partners to date, including 7 of the top 10 pharmaceutical companies Oversubscribed $7M financing proceeds, coupled with revenue, to drive continued growth and launch of next generation products Anil Narasimha, Ph.D. joins as Chief Commercial Officer CAMBRIDGE, Mass.--Today, Portal Biotechnologies, Inc. ("Portal"), a cell engineering platform [...]

Parse Biosciences Welcomes Admera Health as Newest Member of Certified Service Provider Network

Partnership Expands Access to Scalable, High-Quality Single Cell Analysis for Researchers SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that Admera Health, a premier provider of Next-Generation Sequencing services for researchers worldwide, has been certified as part of Parse’s Certified Service Provider (CSP) program. [...]

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

BOSTON--Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of glucose and lactate levels in cell cultures. The combined solution will help scientists measure critical process parameters in bioreactors, offering continuous, real-time analysis without the need for manual sampling. In the field [...]

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a leader in automated platforms for biotherapeutic characterization, today announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterization and development processes. The companies plan to combine their complementary expertise on charge separation (Bio-Techne's MauriceFlex™ System) and liquid chromatography mass spectrometry [...]

Access IBO on Knowledge Center